RESUMO
Medical errors during surgery are usually under-reported and not well studied. During the past decade, increased interest in medical malpractice has been shown by both the public and the authorities. A particularly high risk of medical errors is seen in emergency settings, unexpected change in procedure, or in patients with a high body mass index. Visually or acoustically controlled monitoring before wound closure are recommended to eliminate human error as thoroughly as possible. Prevention remains the key to solving the problem.
Assuntos
Abdome Agudo/etiologia , Abdome Agudo/cirurgia , Corpos Estranhos/etiologia , Corpos Estranhos/cirurgia , Obstrução Intestinal/etiologia , Obstrução Intestinal/cirurgia , Intestino Delgado , Erros Médicos/efeitos adversos , Instrumentos Cirúrgicos/efeitos adversos , Procedimentos Cirúrgicos do Sistema Digestório , Emergências , Feminino , Gangrena , Humanos , Histerectomia/efeitos adversos , Intestino Delgado/patologia , Pessoa de Meia-Idade , Fatores de TempoRESUMO
The authors identified 321 elderly Kansas Medicaid patients with congestive heart failure and examined angiotensin-converting enzyme (ACE) inhibitor use. Using retrospective claims data, ACE inhibitor use was quantified and daily doses compared to a target enalapril-equivalent dose of 20 mg. The cohort patients averaged 80 years of age, 84% were female, and 70% resided primarily in a nursing home. Only 37.8% received an ACE inhibitor. Users were younger than nonusers (t=2.00; p=0.046), but there was no gender difference (odds ratio [OR], 1.4; 95% confidence interval [CI], 0.73, 2.6). ACE inhibitor users averaged eight prescriptions annually, providing approximately 257 medication days (70% of the study period). The average enalapril-equivalent daily dose was 10.6 mg, and only 22% received the target dose. Nursing home residents were less likely to receive an ACE inhibitor than ambulatory patients (OR, 0.55; 95% CI, 0.34, 0.89) but equally likely to receive target doses (OR, 1.3; 95% CI, 0.34, 4.9). ACE inhibitor use in the Kansas Medicaid congestive heart failure population is not consistent with practice guidelines, particularly among older and/or nursing home patients.